NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,068 | -30.6% | 10,550 | -15.2% | 0.00% | -100.0% |
| Q1 2023 | $8,740 | -68.9% | 12,434 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $28,101 | -40.2% | 12,434 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $47,000 | -70.1% | 12,434 | -57.4% | 0.00% | -60.0% |
| Q1 2022 | $157,000 | -91.1% | 29,188 | -73.6% | 0.01% | -91.0% |
| Q4 2021 | $1,756,000 | +329.3% | 110,437 | +401.4% | 0.11% | +296.4% |
| Q3 2021 | $409,000 | +24.7% | 22,024 | +26.9% | 0.03% | +27.3% |
| Q2 2021 | $328,000 | +35.5% | 17,361 | +47.2% | 0.02% | +29.4% |
| Q1 2021 | $242,000 | -40.2% | 11,792 | +256.3% | 0.02% | -55.3% |
| Q2 2020 | $405,000 | -24.7% | 3,310 | -76.7% | 0.04% | -33.3% |
| Q4 2019 | $538,000 | +147.9% | 14,177 | +19.1% | 0.06% | +128.0% |
| Q3 2019 | $217,000 | – | 11,904 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |